+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tofacitinib"

Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032 - Product Thumbnail Image

Ankylosing Spondylitis (AS) - Market Insights, Epidemiology, and Market Forecast - 2032

  • Report
  • February 2022
  • 210 Pages
  • Global
From
Polymyositis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029 - Product Thumbnail Image

Polymyositis Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

  • Report
  • October 2021
  • 104 Pages
  • Global
From
Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • Report
  • October 2019
  • 128 Pages
  • Global
From
Global Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Global Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • November 2022
  • 175 Pages
  • Global
From
Europe Ulcerative Colitis Market Size, Share & Industry Trends Analysis Report By Molecule Type (Small Molecules and Biologics), By Disease Type, By Route of Administration, By Country and Growth Forecast, 2022-2028 - Product Thumbnail Image

Europe Ulcerative Colitis Market Size, Share & Industry Trends Analysis Report By Molecule Type (Small Molecules and Biologics), By Disease Type, By Route of Administration, By Country and Growth Forecast, 2022-2028

  • Report
  • April 2022
  • 85 Pages
  • Europe
From
Global Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027 - Product Thumbnail Image

Global Inflammatory Bowel Disease Treatment Market By Type, By Distribution Channel, By Route of Administration, By Drug Class, By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

  • Report
  • October 2021
  • 288 Pages
  • Global
From
Immunology Drugs Market Report Suite for the United States - 2018-2024 - Product Thumbnail Image

Immunology Drugs Market Report Suite for the United States - 2018-2024

  • Report
  • April 2018
  • United States
From
Rheumatoid Arthritis Market and Forecast Analysis to 2025 - Product Thumbnail Image

Rheumatoid Arthritis Market and Forecast Analysis to 2025

  • Drug Pipelines
  • August 2018
  • 610 Pages
  • Global
From
Psoriatic Arthritis Market and Forecast Analysis 2035 - Product Thumbnail Image

Psoriatic Arthritis Market and Forecast Analysis 2035

  • Drug Pipelines
  • July 2018
  • 503 Pages
  • Global
From
Rheumatoid Arthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Rheumatoid Arthritis Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 91 Pages
  • Global
From
Tyrosine Kinase JAK Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Tyrosine Kinase JAK Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • January 2024
  • 114 Pages
  • Global
From
Dermatomyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Dermatomyositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 64 Pages
  • Global
From
Ulcerative Colitis Market By Disease Type, By Molecule Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2020-2030 - Product Thumbnail Image

Ulcerative Colitis Market By Disease Type, By Molecule Type, By Route of Administration: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • Report
  • March 2022
  • 225 Pages
  • Global
From
Autoimmune Disease Therapeutics Market by Drug Class, Indication and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025 - Product Thumbnail Image

Autoimmune Disease Therapeutics Market by Drug Class, Indication and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025

  • Report
  • February 2019
  • 202 Pages
  • Global
From
Loading Indicator

Tofacitinib is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is a Janus kinase (JAK) inhibitor, which works by blocking the action of certain enzymes that are involved in the body's inflammatory response. Tofacitinib is taken orally, usually twice daily. It is available in both tablet and solution form. Tofacitinib is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2012. It is the first JAK inhibitor to be approved for the treatment of immune disorders. Since its approval, it has become a popular treatment option for many patients. The market for Tofacitinib is highly competitive, with several companies offering the drug. These include Pfizer, Novartis, AbbVie, and Merck. Each company has its own formulation of the drug, and they compete on price, efficacy, and safety. Show Less Read more